1. Home
  2. RYOJ vs PDSB Comparison

RYOJ vs PDSB Comparison

Compare RYOJ & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RYOJ

rYojbaba Co. Ltd. Common Shares

N/A

Current Price

$4.03

Market Cap

42.8M

ML Signal

N/A

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.87

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYOJ
PDSB
Founded
2015
2005
Country
Japan
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.8M
46.0M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
RYOJ
PDSB
Price
$4.03
$0.87
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
71.7K
965.2K
Earning Date
12-19-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
72.91
N/A
EPS
0.13
N/A
Revenue
$11,576,848.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$30.25
N/A
Revenue Growth
5.60
N/A
52 Week Low
$1.81
$0.70
52 Week High
$11.43
$2.28

Technical Indicators

Market Signals
Indicator
RYOJ
PDSB
Relative Strength Index (RSI) N/A 52.09
Support Level N/A $0.70
Resistance Level N/A $0.94
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.02
Stochastic Oscillator 0.00 71.67

Price Performance

Historical Comparison
RYOJ
PDSB

About RYOJ rYojbaba Co. Ltd. Common Shares

rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: